XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Net income $ 55,757 $ 83,295
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 197,478 163,397
Long-lived asset impairment 13,654 20,137
Amortization of deferred financing costs 3,288 4,542
Income from discontinued operations, net of tax (36,496) (32,410)
Amortization of debt discount 11,821 11,314
Provision for (benefit from) doubtful accounts 1,387 (739)
Gain on sale of property, plant and equipment (3,493) (18,906)
Equity in income of non-consolidated affiliates (9,602) (9,387)
Amortization of terminated interest rate swaps 2,353 1,552
Interest rate swaps 151 152
(Gain) loss on remeasurement of intercompany balances (2,882) 469
Stock-based compensation expense 11,303 8,387
Deferred income tax provision (12,575) 10,614
Changes in assets and liabilities, net of acquisition:    
Accounts receivable and notes (29,385) (8,156)
Inventory (3,398) (68,094)
Costs and estimated earnings versus billings on uncompleted contracts (13,882) (118,607)
Other current assets (7,283) 938
Accounts payable and other liabilities (26,568) 31,653
Deferred revenue (27,585) 5,451
Other (3,906) (10,507)
Net cash provided by continuing operations 120,137 75,095
Net cash provided by discontinued operations 2,466 5,520
Net cash provided by operating activities 122,603 80,615
Cash flows from investing activities:    
Capital expenditures (238,210) (214,934)
Proceeds from sale of property, plant and equipment 13,399 71,111
Payment for MidCon acquisition (360,521)  
Return of investments in non-consolidated affiliates 9,799 9,387
Increase in restricted cash (245)  
Cash invested in non-consolidated affiliates (197)  
Net cash used in continuing operations (575,975) (134,436)
Net cash provided by discontinued operations 33,276 29,335
Net cash used in investing activities (542,699) (105,101)
Cash flows from financing activities:    
Proceeds from borrowings of long-term debt 1,389,799 1,474,037
Repayments of long-term debt (1,051,000) (1,407,750)
Payments for debt issuance costs (6,923) (11,929)
Payments above face value for redemption of convertible debt (15,007)  
Payments for settlement of interest rate swaps that include financing elements (1,894) (314)
Net proceeds from the sale of Partnership units 169,471  
Proceeds from stock options exercised 10,767 5,789
Proceeds from stock issued pursuant to our employee stock purchase plan 897 805
Purchases of treasury stock (6,315) (3,515)
Dividends to Exterran stockholders (19,990)  
Stock-based compensation excess tax benefit 7,820 1,026
Distributions to noncontrolling partners in the Partnership (35,291) (30,679)
Net cash provided by financing activities 442,334 27,470
Effect of exchange rate changes on cash and cash equivalents (4,000) (644)
Net increase in cash and cash equivalents 18,238 2,340
Cash and cash equivalents at beginning of period 35,665 34,601
Cash and cash equivalents at end of period 53,903 36,941
Supplemental disclosure of non-cash transactions:    
Shares issued for redemption of convertible debt 219,211  
Shares acquired from exercise of call options $ (89,407)